Zidovudine-phosphate-didanosine dimer
Alternative Names: AZT-P-ddI; IVX-E-59; ScripteneLatest Information Update: 12 Dec 2007
At a glance
- Originator IVAX Corporation
- Developer SSP Co
- Class Antiretrovirals; Azides; Nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 15 Sep 2003 No development reported - Phase-II for HIV infections treatment in USA (unspecified route)
- 28 Jun 2002 Discontinued - Preclinical for HIV infections treatment in Japan (unspecified route)
- 02 Dec 1999 SS Pharmaceuticals is now called SSP Co